Thomas Steyer’s NeoGenomics NEO Stock Holding History

Thomas Steyer’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,000	Closed	-$141K	–	150
2026 Q1	$141K	Hold	19,000	–	–	﹤0.01%	157
2025 Q4	$223K	Buy	+19,000	New	+$205K	﹤0.01%	129
2021 Q4	–	Sell	-529,839	Closed	-$25.6M	–	310
2021 Q3	$25.6M	Buy	529,839 +109,839	+26%	+$5.08M	0.12%	92
2021 Q2	$19M	Buy	+420,000	New	+$18.6M	0.08%	104

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Thomas Steyer's NEO Position: Q2 2026 in Review

Thomas Steyer sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 19,000 shares — an estimated $141K sold.

Thomas Steyer first reported a position in NEO in Q2 2021 and held it in 4 quarters. The position peaked at $25.6M in Q3 2021. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Thomas Steyer reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 19,000 NeoGenomics shares in Q2 2026, an estimated $141K.
Thomas Steyer first reported a position in NeoGenomics in Q2 2021 and held it in 4 quarters.
Thomas Steyer's NeoGenomics position peaked at $25.6M in Q3 2021.
265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.